Greg Ikonen Photo

Industry Experience

CEO

Mendel Biotechnology, Inc.

General Counsel

Arriva Pharmaceuticals, Inc.

Partner

Venture Law Group

Associate

Fried, Frank, Harris Shriver & Jacobson LLP

Greg has spent more than 20 years advising biotech companies on corporate and complex transactional matters, including structuring and negotiating strategic R&D collaborations, interactions with academic institutions, board governance and venture and non-dilutive financings. His mix of business and legal in-house experience enables him to provide pragmatic, business-focused solutions to intricate challenges faced by life sciences companies. Representative clients include Aduro Biotech, Aileron Therapeutics, Open Philanthropy Project and Pliant Therapeutics.

experience +

experience –

Mendel Biotechnology, Inc.

CEO

  • Led the successful sale of its operating business, and subsequently led the team after the acquisition in building out its microbial platform and development of new microbial products
  • Served as Senior Vice President, Corporate Development, where he developed the business case and strategy for the microbial-focused technology platform that drove the acquisition
  • Served as the company’s General Counsel, advising on corporate governance matters, successfully completing equity and R&D financings, negotiating collaboration agreements with BP, Bayer Crop Sciences and the Monsanto Company, and overseeing regulatory matters, including representing the company in the BIO trade association
  • Served as General Counsel for a venture-backed biologics company developing therapies for respiratory diseases

Venture Law Group and Heller Ehrman

Partner

  • Focused on licensing and strategic collaborations for life sciences and technology companies

Recent Client Work +

Recent Client WOrk –

Community +

Community –

Bar Admissions
  • California
  • New York
Education
  • Harvard Law School, J.D., cum laude
  • University of Michigan, B.S., Chemical Engineering